Biotech Target N V - Net Worth and Insider Trading
Biotech Target N V Net Worth
The estimated net worth of Biotech Target N V is at least $442 Million dollars as of 2024-04-29. Biotech Target N V is the 10% Owner of Radius Health Inc and owns about 8,733,538 shares of Radius Health Inc (RDUS) stock worth over $284 Million. Biotech Target N V is the 10% Owner of Macrogenics Inc and owns about 9,929,963 shares of Macrogenics Inc (MGNX) stock worth over $146 Million. Biotech Target N V is also the 10% Owner of Esperion Therapeutics Inc and owns about 4,477,964 shares of Esperion Therapeutics Inc (ESPR) stock worth over $9 Million. Besides these, Biotech Target N V also holds Molecular Templates Inc (MTEM) , Cidara Therapeutics Inc (CDTX) . Details can be seen in Biotech Target N V's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Biotech Target N V has not made any transactions after 2024-04-02 and currently still holds the listed stock(s).
Transaction Summary of Biotech Target N V
Biotech Target N V Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Biotech Target N V owns 5 companies in total, including Radius Health Inc (RDUS) , Esperion Therapeutics Inc (ESPR) , and Cidara Therapeutics Inc (CDTX) among others .
Click here to see the complete history of Biotech Target N V’s form 4 insider trades.
Insider Ownership Summary of Biotech Target N V
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| RDUS | Radius Health Inc | 2022-05-18 | 10 percent owner |
| ESPR | Esperion Therapeutics Inc | 2021-05-24 | 10 percent owner |
| CDTX | Cidara Therapeutics Inc | 2017-11-15 | 10 percent owner |
| MGNX | Macrogenics Inc | 2023-10-02 | 10 percent owner |
| MTEM | Molecular Templates Inc | 2024-04-02 | 10 percent owner |
Biotech Target N V Latest Holdings Summary
Biotech Target N V currently owns a total of 5 stocks. Among these stocks, Biotech Target N V owns 8,733,538 shares of Radius Health Inc (RDUS) as of May 18, 2022, with a value of $284 Million and a weighting of 64.12%. Biotech Target N V owns 9,929,963 shares of Macrogenics Inc (MGNX) as of October 2, 2023, with a value of $146 Million and a weighting of 33.05%. Biotech Target N V also owns 4,477,964 shares of Esperion Therapeutics Inc (ESPR) as of May 24, 2021, with a value of $9 Million and a weighting of 2.01%. The other 2 stocks Molecular Templates Inc (MTEM) , Cidara Therapeutics Inc (CDTX) have a combined weighting of 0.82% among all his current holdings.
Latest Holdings of Biotech Target N V
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| RDUS | Radius Health Inc | 2022-05-18 | 8,733,538 | 32.47 | 283,577,979 |
| MGNX | Macrogenics Inc | 2023-10-02 | 9,929,963 | 14.72 | 146,169,055 |
| ESPR | Esperion Therapeutics Inc | 2021-05-24 | 4,477,964 | 1.99 | 8,888,759 |
| MTEM | Molecular Templates Inc | 2024-04-02 | 1,279,820 | 1.71 | 2,188,492 |
| CDTX | Cidara Therapeutics Inc | 2017-11-15 | 114,764 | 12.67 | 1,454,060 |
Holding Weightings of Biotech Target N V
Biotech Target N V Form 4 Trading Tracker
According to the SEC Form 4 filings, Biotech Target N V has made a total of 9 transactions in Radius Health Inc (RDUS) over the past 5 years, including 9 buys and 0 sells. The most-recent trade in Radius Health Inc is the acquisition of 477,824 shares on May 18, 2022, which cost Biotech Target N V around $3 Million.
According to the SEC Form 4 filings, Biotech Target N V has made a total of 12 transactions in Macrogenics Inc (MGNX) over the past 5 years, including 12 buys and 0 sells. The most-recent trade in Macrogenics Inc is the acquisition of 150,000 shares on October 2, 2023, which cost Biotech Target N V around $669,000.
According to the SEC Form 4 filings, Biotech Target N V has made a total of 7 transactions in Esperion Therapeutics Inc (ESPR) over the past 5 years, including 7 buys and 0 sells. The most-recent trade in Esperion Therapeutics Inc is the acquisition of 100,000 shares on May 24, 2021, which cost Biotech Target N V around $2 Million.
More details on Biotech Target N V's insider transactions can be found in the Insider Trading History of Biotech Target N V table.Insider Trading History of Biotech Target N V
- 1
Biotech Target N V Trading Performance
GuruFocus tracks the stock performance after each of Biotech Target N V's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Biotech Target N V is 6.21%. GuruFocus also compares Biotech Target N V's trading performance to market benchmark return within the same time period. The performance of stocks bought by Biotech Target N V within 3 months outperforms 27 times out of 60 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Biotech Target N V's insider trading performs compared to the benchmark.
Performance of Biotech Target N V
Average Return
-20.88%
Outperforming Transactions
42%
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 7.19 | 6.21 | 0.56 | -20.88 | -48.05 | -51.68 |
| Relative Return to S&P 500(%) | 5.06 | 0.48 | -6.77 | -32.82 | -54.97 | -63.59 |
Biotech Target N V Ownership Network
Ownership Network List of Biotech Target N V
Ownership Network Relation of Biotech Target N V
Biotech Target N V Owned Company Details
What does Radius Health Inc do?
Who are the key executives at Radius Health Inc?
Biotech Target N V is the 10 percent owner of Radius Health Inc. Other key executives at Radius Health Inc include director & CEO and President G. Kelly Martin , Chief Business Officer Chhaya Shah , and Vice President & Sales Danielle Holtschlag .
Radius Health Inc (RDUS) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Radius Health Inc (RDUS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Radius Health Inc (RDUS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Radius Health Inc (RDUS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Radius Health Inc Insider Transactions
Biotech Target N V Mailing Address
Above is the net worth, insider trading, and ownership report for Biotech Target N V. You might contact Biotech Target N V via mailing address: Ara Hill Top Building, Unit A-5, Pletterijweg Oost 1, Curacao, Willemstad P8 000000.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
